cost-CM1102
The aim of the Action is to develop novel nanoscale glycoconjugates suitable for biomedical applications which will be achieved through the following objectives (list of working group participants):
Develop new synthetic methods that will allow the practical production of glycoconjugates for nanoscience applications
Gain new fundamental understanding of multivalent self-assembly and translate these findings into biomedical and industrial nanotechnology applications
Develop non-invasive diagnostic/prognostic tools for cancer and diseases and develop new nano-devices for targeting brain tissues
Develop new immunostimulant species for immunological therapies Develop new anti-adhesion methods for treating pathogenic infections